Your browser doesn't support javascript.
loading
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin.
Mathis, Mitchell V; Muoio, Brendan M; Andreason, Paul; Avila, Amy M; Farchione, Tiffany; Atrakchi, Aisar; Temple, Robert J.
Afiliación
  • Mathis MV; Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Muoio BM; Regulatory Project Manager, Division of Psychiatry Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Ste 4114, Silver Spring, MD 20993. brendan.muoio@fda.hhs.gov.
  • Andreason P; Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Avila AM; Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Farchione T; Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Atrakchi A; Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Temple RJ; Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
J Clin Psychiatry ; 78(6): e668-e673, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28493654
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Piperidinas / Antipsicóticos / United States Food and Drug Administration / Urea / Deluciones / Alucinaciones Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Clin Psychiatry Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Piperidinas / Antipsicóticos / United States Food and Drug Administration / Urea / Deluciones / Alucinaciones Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Clin Psychiatry Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos